Genetic Testing

Cardiac Disease Genetic Testing

By |2020-09-08T10:13:35-05:00July 9th, 2020|Genetic Testing, Heart Disease, Next Generation Sequencing, Precision Medicine|

CARDIAC DISEASE AND GENETIC FACTORS Genes are what make you similar to your relatives. Problems (pathogenic mutations) in genes can cause your family members to be at risk for a [...]

The Role of Genetic Testing in Inherited Cardiovascular Disease

By |2020-09-03T15:42:58-05:00January 20th, 2020|Genetic Testing, Heart Disease, Next Generation Sequencing|

Hereditary Cardiovascular Risk Assessment is the Most Effective Way of Identifying At-Risk Individuals or Confirming a Diagnosis of Existing Cardiac Conditions. It Opens the Door for More Precise and Individualized [...]

Ultra Sensitive Test for Circulating Tumor DNA At Ayass Bioscience!

By |2020-05-17T17:37:53-05:00January 19th, 2017|Circulating Tumor DNA, Genetic Testing, Research|

Detection Of Cancer at Early Stages! MUTATION DETECTION AT LOWER ALLELIC FRIEQUENCY! At Ayass BioScience we use an ultrasensitive method for detecting circulating tumor DNA. We can detect cancer with [...]

Liquid Biopsies – High Sensitivity Cancer Detection

By |2020-05-17T17:37:53-05:00January 16th, 2017|Circulating Tumor DNA, Genetic Testing, Next Generation Sequencing, Research|

SCREENING AND EARLY CANCER DETECTION • REAL TIME MONITORING OF CANCER THERAPY Dying cancer cells shed very small amount of DNA into blood. Gene-sequencing machines decode millions of short fragments [...]

Mitochondrial DNA (mtDNA) Mutation and Myopathy

By |2017-01-13T09:07:34-06:00January 10th, 2017|Genetic Testing, mtDNA, Next Generation Sequencing|

The Mitochondrial genome is extremely small when compared to the nuclear genome, and mitochondrial DNA (mtDNA) mutations are complex and difficult to trace, but they play an important role in [...]

Mass Spectrometry – Proteomics – Metabolomics – for Disease – Specific Biomarkers

By |2020-05-17T17:37:54-05:00December 22nd, 2016|Genetic Testing, Mass Spectrometry, Next Generation Sequencing, Research|

The Proteomics studies that corroborate Metabolomics findings are the next generation of laboratory testing using the Mass Spectrometry, a key technology for targeted protein and metabolite identification and quantification. This assay [...]

Solid Tumor NGS DNA Testing!

By |2017-01-19T11:29:00-06:00December 16th, 2016|Genetic Testing, Next Generation Sequencing, Solid Tumor|

At Ayass BioScience, we use high-throughput Next Generation Sequencing technology to sequence cancer patients' solid tumor DNA (Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Cervical cancer). Targeted sequencing of tumor DNA across our [...]

ctDNA Detection – CLIA Compliant Lab Developed Test!

By |2016-12-08T11:47:55-06:00December 8th, 2016|Circulating Tumor DNA, Genetic Testing, Next Generation Sequencing|

Ayass BioScience Circulating Tumor DNA (ctDNA) Assay is CLIA Compliant Lab Developed Test for Clinical Practice. Ayass BioScience ctDNA detects low levels of circulating tumor DNA (ctDNA) in the blood stream [...]

COVID-19 Testing. COVID-19 Drive-Through Testing Facility. COVID-19 Antibody Testing.

COVID-19 Testing. COVID-19 Drive-Through Testing Facility. COVID-19 Antibody Testing.

Ayass BioScience, LLC

8501 Wade Blvd. Bldg 9, Frisco, TX 750934

Phone: 972-668-6005

Fax: 972-668-6720

Go to Top